XML 53 R30.htm IDEA: XBRL DOCUMENT v3.25.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedule of Revenue Associated with License Agreement we recognized revenue associated with the KKC Commercialization Agreement as follows (in thousands):

 

 

 

 

Timing of Revenue Recognition:

 

 

 

Services performed over time

 

$

743

 

Pass through services at a point in time

 

 

9

 

 

$

752

 

Schedule of Changes in Unbilled Receivables and Contract Liabilities

As of June 30, 2025 and 2024, we had no accounts receivable, unbilled receivables or contract liabilities. A reconciliation of the beginning and ending amount of contract liabilities as of June 30, 2024, which primarily related to the combined performance obligations for the transfer of development services under the KKC Commercialization Agreement and was a separate performance obligation in our contract pursuant to research plans under the agreements were as follows (in thousands):

 

 

June 30, 2024

 

Beginning balance

 

$

317

 

Recognized as revenue:

 

 

 

Revenue recognized upon satisfaction of performance obligations

 

 

(317

)

Revenue recognized from change in estimate for performance
    obligations that are being closed

 

 

 

Revenue recognized for performance obligations that will no longer
    commence

 

 

 

Ending balance

 

$

 

Antidilutive Securities

The following table presents potentially dilutive shares that have been excluded from the calculation of net (loss) income per share because of their anti-dilutive effect (in thousands):

 

 

For the Fiscal Year Ended June 30,

 

 

 

2025

 

 

2024

 

Stock options

 

 

869

 

 

 

1,357

 

Warrants

 

 

103

 

 

 

103

 

Total anti-dilutive shares

 

 

972

 

 

 

1,460